Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Eisai seeks marketing authorisation for lenvatinib from EMA

pharmaceutical-technologyJuly 31, 2017

Tag: Eisai , Lenvatinib , EMA

PharmaSources Customer Service